UK's Smith & Nephew tumbles after confirming failed J&J deal talks, cutting forecast

By Reuters News

** Shares of British medical products maker Smith & Nephew SN.L down 2.6% at 1088.5p, among top losers on FTSE 100 index .FTSE

** Co confirmed reports that it was approached by Johnson & Johnson JNJ.N earlier this year about a potential merger with its orthopaedics business, but those conversations have now ended

** SN cut annual revenue and profit forecasts due to weak growth in its US orthopaedics unit, and expects it to persist through the final quarter
** Up to Tuesday's close, stock had fallen 9.8%, compared with a 7.25% YTD increase in FTSE 100

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.